R&D When is the superbug message going to bite? As existing antibiotics become less effective, we edge closer to a future where routine infections & minor injuries could once again become high risk.
Patients BIO 2025: Planning, not panic, as BIO weighs in on US vaccin... At BIO 2025, vaccines were top of mind as a result of recent actions by HHS. Speakers addressed news head on, but also explored the larger context.
News UK to start "world first" gonorrhoea vaccine programme As infections rise, a world-first gonorrhoea vaccine programme has been launched in the UK.
News Experts deplore Trump's order for US to exit from WHO One of the first acts of President Donald Trump after his inauguration yesterday was to order the start of the US's withdrawal from the WHO.
News New drugs 'benefit patients, but maybe not populations' The money spent by the NHS on newly approved therapies recommended by NICE might have been better spent elsewhere, according to a new study.
News World leaders seek 10% cut in antibiotic resistance deaths In a landmark development, world leaders meeting at the United Nations officially adopted a political declaration on antimicrobial resistance (AMR), which includes a target of a 10% cut in
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.